Ajanta Pharma gets USFDA observation for Paithan facility

10 Feb 2017 Evaluate

Ajanta Pharma’s Paithan facility in Aurangabad has been issued one observation from the US health regulator. The Paithan facility was recently inspected by the US Food and Drug Administration (USFDA) and had been issued one procedural related ‘483’. The company is in the process of responding to the same within the stipulated time prescribed by USFDA.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.



Ajanta Pharma Share Price

2917.50 147.25 (5.32%)
01-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.25
Dr. Reddys Lab 1250.80
Cipla 1499.60
Zydus Lifesciences 913.40
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×